President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...

Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

the drug does not have approval from the Food and Drug Administration (FDA) for this use. However, Medicare may cover Spravato, an FDA-approved drug with an active ingredient deriving from ketamine.

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

The U.S. Food and Drug Administration (FDA ... See the 10 stocks » However, the Centers for Medicare and Medicaid Services (CMS) could soon throw a monkey wrench into Novo Nordisk's momentum.

Medicare prescription drug plans ... This is because, as per the Food and Drug Administration (FDA), generic drugs may cost around 80% to 85% less than their brand-name equivalents.